Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab to reduce central nervous system side effects after brain radiotherapy in patients with various brain t…
-
CLINICAL_TRIALS trial_result · 2013-06-14Clinical Trial Update: Irinotecan in Treating Children With Refractory Solid Tumors [Phase 2]
A Phase 2 trial evaluating irinotecan in children with refractory solid tumors has completed, with results reported by the Children's Oncolo…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [Phase 1]
Phase 1 evaluation of vorinostat in combination with temozolomide in children with relapsed or refractory primary brain tumors or spinal cor…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma [Phase 2]
A Phase 2 clinical trial of a biological therapy following surgery and radiation for primary or recurrent Astrocytoma or Oligodendroglioma h…
-
CLINICAL_TRIALS research · 2013-01-16Clinical Trial Update: Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma [NA]
A terminated clinical trial evaluated the use of EF5 to measure oxygen levels in tumor cells of patients with newly diagnosed supratentorial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma [Phase 2]
Phase 2 trial evaluating bevacizumab combined with irinotecan in pediatric patients with recurrent or progressive brain tumors including gli…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors [Phase 2]
Phase 2 trial evaluating temozolomide in patients with recurrent oligodendroglial brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors [Phase 2]
Phase 2 trial evaluating temozolomide in patients with recurrent oligodendroglial tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma [Phase 2]
This Phase II study evaluating temozolomide in combination with O6-benzylguanine for temozolomide-resistant anaplastic glioma was terminated…
-
CLINICAL_TRIALS trial_result · 2012-02-06Clinical Trial Update: Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors [Phase 1, Phase 2]
This clinical trial update summarizes the results of a Phase 1/2 study evaluating lapatinib in pediatric patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas [Phase 2]
Phase II trial of irinotecan hydrochloride in recurrent anaplastic astrocytoma, mixed malignant glioma, and oligodendroglioma was terminated…
-
CLINICAL_TRIALS research · 2011-08-30Clinical Trial Update: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
This completed clinical trial investigated molecular and metabolic markers in oligodendrogliomas and compared them with other brain tumors.
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas [Phase 1, Phase 2]
A pediatric Phase 1/2 trial evaluated gefitinib in combination with radiation therapy for newly diagnosed gliomas; the study completed and r…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) [Phase 2]
Phase 2 trial evaluating continuous 28-day temozolomide in patients with recurrent malignant glioma who failed the standard 5-day regimen; r…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Prolonged Daily Temozolomide for Low-Grade Glioma [Phase 2]
Phase 2 trial results from Dana-Farber Cancer Institute evaluate prolonged daily temozolomide in patients with low-grade glioma, including a…
-
CLINICAL_TRIALS research · 2009-07-17Clinical Trial Update: A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma [Phase 1, Phase 2]
This clinical trial update describes a study of 131I-TM601 in adults with recurrent malignant glioma across Phase 1 and Phase 2, with the cu…
-
CLINICAL_TRIALS research · 2009-07-17Clinical Trial Update: Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma [Phase 1]
This document reports a Phase 1 safety and dose-finding trial of TM-601 in adults with recurrent malignant glioma, including glioblastoma. T…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [Phase 1]
Phase 1 study evaluating the combination of motexafin gadolinium and temozolomide in malignant gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-17Clinical Trial Update: Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide [Phase 3]
Phase III randomized study comparing sequential radiochemotherapy with PCV (procarbazine, lomustine, vincristine) versus temozolomide in pat…